Takeda Pharmaceutical Company Limited Operating Income

Takeda Pharmaceutical Company Limited (TKPHF) currently reports a operating income of $650B as of September 2026. That compares with $250B in the prior-year period — up 164.0% year over year. Use the charts on this page to explore Takeda Pharmaceutical Company Limited's operating income history and peer comparisons.

Takeda Pharmaceutical Company Limited's operating income increased from $250B to $650B — a 164.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Takeda Pharmaceutical Company Limited reported $650B in operating income as of September 2026. That compares with $250B in the prior-year period — up 164.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $650B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Takeda Pharmaceutical Company Limited, and consider following TKPHF for alerts when major investors trade the stock.

Takeda Pharmaceutical Company Limited is classified in the Healthcare sector. On operating income, it currently shows $650B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TKPHF with unrelated industries.